Omniid-D Capsule contains a combination of Domperidone 10 mg and Omeprazole 20 mg, formulated to manage gastrointestinal disorders characterized by acid reflux, indigestion, and delayed gastric emptying. Domperidone is a peripheral dopamine D2 receptor antagonist that enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, leading to prolonged reduction of gastric acidity. The combined action of these agents provides symptomatic relief in conditions such as gastroesophageal reflux disease (GERD), dyspepsia, and peptic ulcer disease. Omniid-D Capsule is indicated for patients requiring both acid suppression and prokinetic therapy to alleviate symptoms and promote mucosal healing. It should be used under medical supervision, with caution advised in patients with known hypersensitivity to either component, hepatic impairment, or cardiac arrhythmias. Common side effects may include headache, dry mouth, abdominal cramps, and diarrhea. Patients are advised to follow prescribed dosages and consult healthcare providers if symptoms persist or worsen.